Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations
Crossref DOI link: https://doi.org/10.1007/s12254-014-0156-6
Published Online: 2014-07-15
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Balmelli, Cathrin
Mark, Michael
Spirig, Christian
Spataro, Vito
Pederiva, Stefanie
Monnerat, Christian
Zippelius, Alfred
Wicki, Andreas
Text and Data Mining valid from 2014-07-15